首页> 外文期刊>妇产科期刊(英文) >Sertoli-Leydig Cell Tumor from Latifa Hospital, Dubai UAE: Case Report
【24h】

Sertoli-Leydig Cell Tumor from Latifa Hospital, Dubai UAE: Case Report

机译:阿联酋迪拜拉蒂法医院的Sertoli-Leydig细胞肿瘤:病例报告

获取原文
获取原文并翻译 | 示例
       

摘要

Sertoli-Leydig cell tumors (SLCTs) are rare tumors. Mass and pain are the presenting feature. The varying histopathology and differentiation of this tumor present difficulties with proper diagnosis and development of optimal treatment regimens. The prognosis depends on tumors grading and staging. Surgery is main stay management option. Chemotherapy and radiation options are still of choice.?We aimed?to?present Sertoli-Leydig cell tumor managed surgical at Latifa Hospital in Dubai, UAE with acceptable outcome and good patient satisfaction.
机译:Sertoli-Leydig细胞肿瘤(SLCTS)是罕见的肿瘤。质量和疼痛是提出的功能。这种肿瘤的不同组织病理学和分化存在困难,具有适当的诊断和发展的最佳治疗方案。预后取决于肿瘤分级和分期。手术是主要的服务选项。化疗和辐射选择仍然是首选。我们瞄准了?到?目前Sertoli-Leydig细胞肿瘤在迪拜的拉脱氏医院管理外科,阿联酋具有可接受的结果和良好的患者满意度。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号